Rare Disease

Planning for Accelerated Approval: Timing is Everything

Planning for Accelerated Approval: Timing is Everything

Short on time? Watch focused clips featuring practical insights, implementation strategies, and expert perspectives from across the session before diving into the full webinar.



Whether you’re evaluating accelerated approval for a development program or preparing for evolving FDA expectations, our experts can help. Use the Ask Our Experts link below to discuss your development strategy, confirmatory trial planning, and regulatory readiness.

Ask Our Experts  

Ready to get started? So are we.

Drop us a line to learn more about how we can help.

Contact Us Now  

Recent Insights

Planning for Accelerated Approval: Timing is Everything
Rare Disease

Planning for Accelerated Approval: Timing is Everything
Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
Rare Disease

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
Returning Patient Data in Rare Disease Studies
Rare Disease

Returning Patient Data in Rare Disease Studies
The Current State of Rare Disease Development: Regulatory, Operational, and Patient-Centered Strategies
Rare Disease

The Current State of Rare Disease Development: Regulatory, Operational, and Patient-Centered Strategies
Top Considerations Sponsors Need to Know About Rare Disease Regulation 
Rare Disease

Top Considerations Sponsors Need to Know About Rare Disease Regulation 
How the FDA Is Shaping the Future of Rare Disease Regulation 
Rare Disease

How the FDA Is Shaping the Future of Rare Disease Regulation 
Flexibility Drives Success in Rare Disease Trials 
Rare Disease

Flexibility Drives Success in Rare Disease Trials 
World Patient Safety Day: Safer Research for Children
Rare Disease

World Patient Safety Day: Safer Research for Children